TaiwanBio Therapeutics
TaiwanBio Therapeutics Inc. a clinical-stage biotech company focusing on developing novel cell therapies. Our proprietary technology platforms enable us to perform safe and effective cell engineering, making our cell products more potent than conventional cell therapies. TaiwanBio’s SuperCarrier MSC is a cutting-edge, genetically engineered cell therapy with an unparalleled growth factor or cytokine secretion ability. At TaiwanBio, we are an expert in developing engineered cells to treat non-oncology diseases. Our innovative vector platform allows us to engineer various cell types.
